These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35054871)

  • 1. Functional In Vitro Assessment of VEGFA/NOTCH2 Signaling Pathway and pRB Proteasomal Degradation and the Clinical Relevance of Mucolipin TRPML2 Overexpression in Glioblastoma Patients.
    Santoni G; Amantini C; Nabissi M; Arcella A; Maggi F; Santoni M; Morelli MB
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of TRPML1 and TRPML2 Mucolipin Channels Affects the Survival of Glioblastoma Patients.
    Santoni G; Maggi F; Amantini C; Arcella A; Marinelli O; Nabissi M; Santoni M; Morelli MB
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients.
    Morelli MB; Nabissi M; Amantini C; Maggi F; Ricci-Vitiani L; Pallini R; Santoni G
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-myc Downstream-Regulated Gene 1 (NDRG1) Regulates Vascular Endothelial Growth Factor A (VEGFA) and Malignancies in Glioblastoma Multiforme (GBM).
    Zhang X; Chen Q; Li Y; Chen H; Jiang Q; Hu Q
    Biomed Res Int; 2022; 2022():3233004. PubMed ID: 35813230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of Notch2 signalling confers chemoresistance to neural stem cells via transactivation of fibroblast growth factor receptor-1.
    Tomé M; Tchorz J; Gassmann M; Bettler B
    Stem Cell Res; 2019 Mar; 35():101390. PubMed ID: 30763736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
    Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
    Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSMB8 inhibition decreases tumor angiogenesis in glioblastoma through vascular endothelial growth factor A reduction.
    Chang HH; Cheng YC; Tsai WC; Chen Y
    Cancer Sci; 2020 Nov; 111(11):4142-4153. PubMed ID: 32816328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FRAT1 promotes the angiogenic properties of human glioblastoma cells via VEGFA.
    Yang B; Liu D; Ren YQ; Sun YQ; Zhang JP; Wang XG; Wu YQ; Wang SL; Guo SH; Guo G
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35059733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
    Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
    J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling.
    Deng J; Liu AD; Hou GQ; Zhang X; Ren K; Chen XZ; Li SSC; Wu YS; Cao X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):2. PubMed ID: 30606241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
    Lucio-Eterovic AK; Piao Y; de Groot JF
    Clin Cancer Res; 2009 Jul; 15(14):4589-99. PubMed ID: 19567589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme.
    Huang SX; Zhao ZY; Weng GH; He XY; Wu CJ; Fu CY; Sui ZY; Ma YS; Liu T
    Biochem Biophys Res Commun; 2017 May; 486(4):1129-1136. PubMed ID: 28389242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of angiogenesis related factors in glioblastoma, peritumoral tissue and their derived cancer stem cells.
    D'Alessio A; Proietti G; Lama G; Biamonte F; Lauriola L; Moscato U; Vescovi A; Mangiola A; Angelucci C; Sica G
    Oncotarget; 2016 Nov; 7(48):78541-78556. PubMed ID: 27705944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGD5 sustains vascular endothelial growth factor A (VEGFA) signaling through inhibition of proteasome-mediated VEGF receptor 2 degradation.
    Heldin J; O'Callaghan P; Hernández Vera R; Fuchs PF; Gerwins P; Kreuger J
    Cell Signal; 2017 Dec; 40():125-132. PubMed ID: 28927665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGB1-Induced p62 Overexpression Promotes Snail-Mediated Epithelial-Mesenchymal Transition in Glioblastoma Cells via the Degradation of GSK-3β.
    Li H; Li J; Zhang G; Da Q; Chen L; Yu S; Zhou Q; Weng Z; Xin Z; Shi L; Ma L; Huang A; Qi S; Lu Y
    Theranostics; 2019; 9(7):1909-1922. PubMed ID: 31037147
    [No Abstract]   [Full Text] [Related]  

  • 17. Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas.
    Sivasankaran B; Degen M; Ghaffari A; Hegi ME; Hamou MF; Ionescu MC; Zweifel C; Tolnay M; Wasner M; Mergenthaler S; Miserez AR; Kiss R; Lino MM; Merlo A; Chiquet-Ehrismann R; Boulay JL
    Cancer Res; 2009 Jan; 69(2):458-65. PubMed ID: 19147558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.
    Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS
    J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastoma.
    Li Y; Liu X; Zhao F; Zhao Z; Li X; Wang J; Huang B; Chen A
    CNS Neurosci Ther; 2024 Feb; 30(2):e14366. PubMed ID: 37485655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective agonist of TRPML2 reveals direct role in chemokine release from innate immune cells.
    Plesch E; Chen CC; Butz E; Scotto Rosato A; Krogsaeter EK; Yinan H; Bartel K; Keller M; Robaa D; Teupser D; Holdt LM; Vollmar AM; Sippl W; Puertollano R; Medina D; Biel M; Wahl-Schott C; Bracher F; Grimm C
    Elife; 2018 Nov; 7():. PubMed ID: 30479274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.